QLENX
Price
$16.37
Change
+$0.08 (+0.49%)
Updated
Nov 13 closing price
SAOCX
Price
$19.50
Change
-$0.05 (-0.26%)
Updated
Nov 13 closing price
Ad is loading...

QLENX vs SAOCX

Header iconQLENX vs SAOCX Comparison
Open Charts QLENX vs SAOCXBanner chart's image
AQR Long-Short Equity N
Price$16.37
Change+$0.08 (+0.49%)
VolumeN/A
CapitalizationN/A
NAA Opportunity Fund C
Price$19.50
Change-$0.05 (-0.26%)
VolumeN/A
CapitalizationN/A
QLENX vs SAOCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QLENX vs. SAOCX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QLENX is a Hold and SAOCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 2.07B vs. SAOCX (38.6M). QLENX pays higher dividends than SAOCX: QLENX (18.52) vs SAOCX (0.00). QLENX was incepted earlier than SAOCX: QLENX (11 years) vs SAOCX (21 years). SAOCX is a more actively managed with annual turnover of: 309.00 vs. QLENX (0.00). QLENX (2500) and SAOCX (2500) have matching initial minimum investment requirements. QLENX annual gain was more profitable for investors over the last year : 25.63 vs. SAOCX (15.82). QLENX return over 5 years is better than : 96.88 vs. SAOCX (29.57).
QLENXSAOCXQLENX / SAOCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years21 years-
Gain YTD26.67215.818169%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.07B38.6M5,352%
Annual Yield % from dividends18.520.00-
Returns for 1 year25.6315.82162%
Returns for 3 years94.5819.44487%
Returns for 5 years96.8829.57328%
Returns for 10 years126.2217.78710%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZOM0.140.02
+14.38%
Zomedica Corp
EVRG63.680.40
+0.63%
Evergy
HOTH0.89N/A
-0.06%
Hoth Therapeutics
AVAL2.00-0.01
-0.50%
Grupo Aval Acciones Y Valores SA
MLYS13.38-1.54
-10.32%
Mineralys Therapeutics